TREAT (Telemedicine for Reach, Education, Access, and Treatment)
NCT ID: NCT01339208
Last Updated: 2015-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
35 participants
INTERVENTIONAL
2011-06-30
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Telemedicine for Reach, Education, Access, and Treatment for Diabetes Self-Management Education and Support
NCT06626347
Telemedicine for Reach, Education, Access and Treatment-ongoing
NCT04107935
Enhancing Telemedicine for T2D
NCT06740435
Telehealth for Diabetes Self-Management
NCT00194805
Diabetes Remote Intervention to improVe Use of Evidence-based Medications
NCT06046560
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telemedicine Diabetes Intervention
Telemedicine diabetes intervention
3 month duration telemedicine consultation and diabetes education
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telemedicine diabetes intervention
3 month duration telemedicine consultation and diabetes education
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Referral by a primary care provider.
* HbA1c equal or greater than 7.0%.
Exclusion Criteria
* Gestational Diabetes
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Department of Defense
FED
University of Pittsburgh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Linda Siminerio
Director Diabetes Institute
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frederico Toledo, MD
Role: PRINCIPAL_INVESTIGATOR
University of Pittsburgh
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UPMC Northwest
Seneca, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Toledo FG, Ruppert K, Huber KA, Siminerio LM. Efficacy of the Telemedicine for Reach, Education, Access, and Treatment (TREAT) model for diabetes care. Diabetes Care. 2014 Aug;37(8):e179-80. doi: 10.2337/dc13-1909. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRO10100547
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.